Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610717-24-000555
Filing Date
2024-12-27
Accepted
2024-12-27 17:01:21
Documents
1
Period of Report
2024-12-27

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 8385
  Complete submission text file 0001610717-24-000555.txt   9890
Mailing Address 11080 CIRCLEPOINT RD., STE, 200 WESTMINSTER CO 80020
Business Address
BERNS PAUL L (Reporting) CIK: 0001202769 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41802 | Film No.: 241586218

Mailing Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 (857) 760-0900
Neumora Therapeutics, Inc. (Issuer) CIK: 0001885522 (see all company filings)

EIN.: 844367680 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)